Glucose in non-invasively collected biofluids is generally in the micromolar range and thus, requires sensing methodologies capable of measuring glucose at these levels. Here, we present a small fluorometer system that can quantify glucose in the range of 0-5 μM with resolution of ∼0.07 μM. It relies on the glucose binding protein (GBP) fluorescently labeled with two fluorophores. Fluorescence signals from the dual-labeled GBP are utilized in a ratiometric mode, making the measurements insensitive to variations in protein concentration and other systematic errors. Fluorescence is quantified by a miniature, dedicated ratiometric fluorometer that is powered via USB. Concentration is calculated using an ultra-mobile personal computer. The whole system is designed to be pocket sized suitable for point-of-care or bedside applications. Test results suggest that the system is a promising tool for accurate measurements of low glucose concentrations (0.1-10 μM) in biological samples.
Introduction
Accurate monitoring of glucose concentrations is an essential component of biomedical monitoring and diagnosis. Glucose is the major energy source for cells and is thus involved directly or indirectly in many metabolic pathways. The standard medical practice is to measure blood or plasma glucose levels either with a portable glucose meter or with more sophisticated instrumentation in the laboratory. Blood and plasma glucose concentrations range from about 3.0-20 mM spanning the hypoglycemic to hyperglycemic spectrum. There are other biofluids of biomedical interest but with glucose concentrations in the μM range. These are saliva (∼70 μM glucose) [1, 2] , tears (∼200 μM) [3, 4] and sweat (∼120 μM) [5, 6] . Our group recently reported on transdermal glucose that can easily reach 30-50 μM [7] . These sources of glucose have shown some correlation with blood glucose. But the interest rests mainly on being able to collect the samples non-invasively. The ability to measure blood glucose without a needle prick and with minimal or no pain has been the holy grail of diabetes research. The rationale is that without pain and skin disruption, compliance with glucose testing and monitoring would significantly increase. This in turn will lead to better management of diabetes and its complications.
Current technology for glucose sensing uses the glucose oxidase/dehydrogenase biosensor system (hexokinase is also used but not as widely) [8] [9] [10] . These enzyme biosensors work very well in the mM blood/plasma glucose range. Some applications directly measure the fluorescence of the enzyme cofactor [11] , while others utilize labeling with quantum dots [12] . However, as the concentrations approach single μM levels, device design becomes increasingly difficult and not amenable to low-cost and portability.
There are also several non-enzymatic approaches which explore equilibrium reactions. One of the most advanced is the combined use of surface plasmon resonance readout with glucose binding polymer [13, 14] , which can achieve a limit of detection in the high micromolar range.
One alternative to the glucose oxidase/dehydrogenase biosensor is a system based on the glucose binding protein (GBP) [15] [16] [17] [18] [19] [20] [21] [22] [23] . In gram-negative bacteria, GBP is responsible for detecting and binding to minute amounts of glucose that diffuse into the periplasmic space, then transporting the glucose to a membrane bound receptor for ATP-fueled transport into the cytoplasm or as a cue for chemotaxis. The GBP is highly specific to glucose and is sensitive to μM concentrations. Our group has converted the GBP into a ratiometric fluorescent glucose biosensor [15] , which is in the heart of the described system.
As previously mentioned, biofluids collected by noninvasive means require a biosensor that is sensitive in the μM range. The fluorescence-based GBP sensor is designed as an alternative to the current glucose oxidase/dehydrogenase sensor system. Our own interest is in measuring transdermal glucose passively collected in a small volume of water sitting on the surface of the skin. We showed that the amount of glucose transported by passive diffusion through the skin follows the trend of blood glucose [7] . We were able to show the feasibility of this method by analyzing the transdermal glucose samples with a GBP assay on a bench-top, lab-grade fluorometer. However, for non-invasive transdermal glucose sensing to become a true alternative to the commercial glucometer, a handheld device that can be used for bedside or home care application is necessary.
There are very few commercially available portable fluorometers. One such example of a minifluorometer is the device manufactured by Ocean Optics and is somewhat portable, but geared toward laboratory use. It is costly and is available at a price tag of several thousand dollars. Existing lower cost fluorometers (i.e. Turner design) are single excitation single emission instruments and obviously cannot be used to measure the emission at two wavelengths of a duallabeled biosensor. These devices are primarily used in water analysis (e.g. measurement of chlorophyll, optical brighteners as contaminants, fluorescent tracers).
In this paper, we present a USB powered, all-solidstate, hand-held fluorometric system for the measurement of low glucose concentrations. It utilizes the dual-labeled GBP as sensor and a dedicated low-cost, dual emission microfluorometer. The design, construction and testing of this device is described here.
Theory of operation
The system is based on the use of a dual-labeled GBP. The wild type of the protein is responsible for glucose sensing and transport in E. coli. In this study, we used a mutant of GBP that has a single cysteine mutation positioned at an allosteric site [15] . The protein is subsequently labeled at the mutation with polarity sensitive fluorophore for signal transduction, as well as with a second dye at the N-terminal for reference. The exact details and the spectroscopic studies of the resulting protein are given in [15] . Briefly, when no glucose is present, the protein assumes an 'open' position (figure 1). The polarity probe, which resides on the other side of the 'hinge', is enclosed in a hydrophobic 'pocket'. This results in high intensity of the emission. In the presence of glucose, the protein switches to a 'closed' position thus exposing the probe to water. Its emission gets quenched ( figure 1(B) ). The second label is not environmentally sensitive thereby serving as a reference. The higher the concentration of the glucose, the lower the signal from the sensing dye, while the intensity from the reference dye is relatively constant. The ratio of the emission at the two peaks is used to quantify the glucose concentration. The two dyes are excited on the same wavelength, but they exhibit two distinct emission maxima. When measuring glucose, a solution with known concentration of the protein is mixed with the sample in a cuvette and the fluorescence is read using the developed fluorometer.
Quantitatively the equilibrium reaction between glucose Gl and GBP is described by the equation
where glGBP denotes the resulting protein-glucose complex. 
The total concentration of the glucose [T G ] can be determined as a sum of the free glucose concentration [Gl] and the bound glucose concentration the total concentration of GBP will be the sum of the concentrations of the free and bound GBP:
[
Substituting (2) and (3) and rearranging, we obtain
where k is the dissociation constant of the reaction (k = 1/K). The block diagram of the ratiometric fluorometer that is used for quantification is shown in figure 2 . The light from a single LED is used to excite the fluorescence. The sample cuvette is 'sandwiched' between two photodetectors equipped with bandpass filters. The intensities corresponding to the emission at 520 and 600 nm are quantified simultaneously and sent to the host computer. There, the ratio of the two intensities R is calculated and stored for analysis. Fluorescence intensity at 600 nm, F 600 is insensitive to glucose concentration, while fluorescence intensity at 520 nm, F 520 , decreases with increasing glucose concentration. Quantitatively, the fluorescence intensity can be found as
where I is the intensity of the absorbed light, I 0 is the intensity of the excitation, ε is the molar extinction coefficient at the exciting wavelength, l is the layer thickness, [C] is the concentration, Q is the quantum yield and f λ is the probability that the emission will occur at the respective emission wavelength. When the concentration of the fluorescent species is low (i.e. the absorption is <0.05), most of these variables can be lumped in a single coefficient a λ , yielding
After substituting (5) for the respective species and wavelengths in (3), we obtain
where R 0 is the ratio measured in the absence of glucose, R min is the ratio when the protein is saturated with glucose, [T GBP ] is the protein concentration and R is the actual measured ratio. For full details of the derivation, the reader is referred to the supplementary information available at stacks.iop.org/MST/25/025701/mmedia.
Experimental details

Materials
6-Acryloyl-2-dimethylaminonaphthalene (acrylodan) and tris(2-carboxyethyl)phosphine (TCEP) were purchased from Molecular Probes (Eugene, OR). Glucose, DEAE Sephadex A-50, N,N-dimethylformamide (DMF), NaCl, KH 2 PO 4 , Na 2 HPO 4 , NaH 2 PO 4 and MgCl 2 were purchased from SigmaAldrich. Tryptone and yeast extract were obtained from Becton Dickinson (Sparks, MD). All chemicals were used without further purification.
Biosensor
The dual-labeled GBP biosensor was prepared as described in [16, 17] . Briefly, modifications to the GBP structure to convert it into a fluorescence-based biosensor involved introducing a cysteine mutation at an allosteric site at the 255 position. The GBP was labeled with the polarity sensitive dye, acrylodan in the S255C position, which then responds to increasing glucose concentrations by decreasing fluorescence intensity [16] . A second dye, a ruthenium metal ligand complex (Ru) was attached to the N-terminal of the protein as a reference, allowing for ratiometric measurements. Ru is a good reference because it is not influenced by the protein conformational changes and its fluorescence lifetime is ∼200 times longer than acrylodan [16, 17] . The GBP glucose-free and glucosebound structures and the corresponding fluorescence emission spectra are shown in figure 1.
Microfluorometer system
The handheld glucose detection system presented in figure 2 consists of electronics integrated with optics (figure 2(A)); a custom microcuvette to hold both sample and GBP biosensor (figure 2(B)); and an ultra-mobile personal computer (UMPC) to control the system and serve as visual interface with the user ( figure 2(C) ).
Optics
The dual-labeled GBP is excited using a 400 nm LED (UV5TZ-395-15, Bivar, CA) and the resulting emission is filtered using a violet-blue Hoya glass filter B-390 (Edmund Optics). To decrease the coupling of the excitation light with the cuvette walls, which may result in unwanted background fluorescence, the beam is shaped using a rectangular aperture to a divergence less than 5
• . A mirror made of aluminized Mylar sheet was attached on the wall opposite to the excitation aperture to increase the excitation intensity. In this way, the excitation intensity was effectively doubled.
Emission is detected using photodiodes S12232-01 (Hamamatsu). These are fast PIN photodiodes with a large surface area (14 mm 2 ). They are positioned on both sides of the cuvette in a 'sandwich' configuration (figure 2). The photodiodes are equipped with interference filters which allowed selecting the emission from the assay in the 500-550 ('green band') and 570-630 ('red band') nm regions. These bands correspond to the acrylodan and Ru emissions, respectively.
Electronics
The LED was driven by a fast voltage-controlled current source (VCCS) to ensure that the excitation intensity is stable when the LED is on. By delivering a square wave voltage on the VCCS input, the sample is excited with modulated light. The amplitude of the light can be independently varied by a digitalto-analogue converter (DAC 7571, Texas Instruments).
Photodiodes were employed to detect the fluorescence intensity by generating current proportional to the intensity of the light that reaches them. Because photodiodes do not exhibit internal amplification as do photomultipliers or avalanche photodiodes, the photocurrent is converted to voltage using an op amp in transimpedance differential configuration thereby ensuring amplification.
The amplifier was calculated to provide a transimpedance gain of 10 8 . A single stage transimpedance amplifier with such gain would be difficult to realize, as it would require a feedback resistor of 100 M . Such high resistances are close to the surface resistance of the printed circuit board, on which the amplifier is mounted, and there is a definite possibility for leakage currents and the ambient humidity to affect the measurements. Therefore, a two-stage amplification system was employed: the first stage is with 10 7 transimpedance using OPA 301 (Texas Instruments) and second stage is with additional amplification of 20. The second stage was separated from the first using a blocking capacitor, which prevented the dc offsets from the output of the first stage being amplified. The maximum amplification was in the band between 5 and 20 kHz. The output of the second stage was digitized using a fast analogue-to-digital converter (16 bit ADC, ADS8318, Texas Instruments) with a maximum throughput of 500 kilosamples per second. It is read by a microcontroller (MSP430F2272, Texas Instruments), which performs both the LED control and the timed acquisition of the intensities.
Detection algorithm
The LED was modulated at 10 kHz. Due to the high amplification, the output of the photoamplifier reaches steady state after the LED transition (on to off or vice versa) in about 20 μs; therefore, an ADC conversion is performed approximately 30 μs after the LED transition. Ten thousand measurements are made when the LED is on and 10 000 measurements are made again when the LED is off. A running sum is calculated according to the following formula: 
where I x LED on is the measured light intensity that includes both the fluorescence and any ambient light and I x LED off is the ambient light only. Because the measurements are taken at regular time intervals (50 μs), this algorithm results in a 'software lock-in' that allows the detection of relatively low fluorescence signals in the presence of relatively high background noise.
Values for the green and red emission intensities were acquired simultaneously and the resulting sums (at 32 bit each) were transferred to a PC. The computer provides power through the USB bus that is also used for bi-directional communication. A Labview-based program controls the electronics and offers the option to adjust the brightness of the LED. When a measurement is initiated, the program receives the measured green and red values and calculates their ratio. The data are saved with tags that allow identification of each measurement. A regular PC (laptop, desktop) can be used for the control or an UMPC (Viliv S5) for mobile measurements.
Sample holder
The sample and the dual-labeled GBP are added in a miniature, 1.6 mm path length cuvette ( figure 2(B) ). The cuvette is designed to be filled and emptied manually using a micropipette. The total volume of the cuvette is 80 μL. The bottom was intentionally rounded to simplify solution loading and unloading. The cuvette was constructed from three layers of extruded polymethyl methacrylate (PMMA), cut to the desired shape either by using a laser cutter, or an in-house CNC milling center (www.littlemachineshop.com). The layers were annealed to avoid cracking, then glued together either using thermal bonding or through solvent bonding.
Calibration
To construct the calibration curve, 200 μL of a 6 μM solution of dual-labeled GBP was added into a quartz cuvette and the fluorescence spectrum was measured on a lab-grade steady-state fluorometer (Cary Eclipse, Varian). Excitation wavelength is set at 390 nm and the spectrum was traced from 420 to 700 nm. Eighty microliter of this solution was transferred to the custom cuvette and measured on the microfluorometer. The custom cuvette has a rounded bottom to prevent the loss of solution during manual transfer. After measurement, the solution is returned to the quartz cuvette by a micropipette with a long neck. One microliter of 400 μM glucose was added to the GBP, mixed and the fluorescence spectrum was measured similarly as before. Repeating the process, 80 μL of this mixture was transferred to the microcuvette and measured with the microfluorometer. A total of six consecutive additions and measurements was performed. The total volume of glucose added to the GBP solution is 6 μL, or a 3% change in volume, which was presumed to affect the fluorescence of GBP to a negligible degree.
A second calibration curve was constructed by adding 40 μL buffer (and subsequently 4, 8, 10 and 16 μM glucose) to 40 μL of the 6 μM GBP to verify that the dual-labeled protein activity is insensitive to the 1:1 dilution (i.e. while intensity is halved, the ratio of green to red emission stays the same). Additionally, 1:1 mixing ratio is better suited for the protocol for transdermal glucose sampling as described below.
Skin sampling
An Eppendorf tube (2 mL) is cut to a height 6 mm from the top. The cylindrical portion with the collar was used to confine sampling to approximately 1 cm 2 area of skin by holding it in place with a finger. Two hundred microliter of water was added to the well and gently aspirated with a pipette for 5 min. The wash was then transferred into another Eppendorf tube for storage at −20
• C or directly to assay. Forty microliter of this solution is withdrawn, mixed with 40 μL protein solution in the custom cuvette and immediately measured using the microfluorimeter.
Results and discussion
Fluorometer design and operation
This system is intended for point-of-care measurement of low (0.1-2 μM) glucose concentrations sampled from the skin surface of patients. Therefore, the device is required to be portable, sensitive, simple to operate, rugged and safe. For these reasons, an LED and photodiodes were chosen respectively as excitation source and detector for the microflurometer. Consequently, the overarching challenge is to make the microfluorometer sensitivity comparable to a lab-grade fluorometer that utilizes a flash lamp rather than an LED for excitation and a photomultiplier tube rather than a photodiode as detector.
The dyes used for labeling of the GBP are acrylodan (Ex max = 390 nm) at the 255 position and ruthenium bis(2,2 -bipyridyl)-1,10-phenanthroline-9-isothiocyanate (Ex max = 450 nm) at the N-terminal. The emission maxima are 530 and 610 nm, respectively. Excitation of these dyes at two different wavelengths would have been impractical as two different light sources must be employed and their light paths aligned. However, upon examination of the excitation profile of the Ru dye, it was noted that the excitation efficiency at 390 nm is ∼85% of the maximum. Thus, it is possible to excite both dyes fairly well with a single light source, in this case, a violet LED. Furthermore, a fairly wide bandpass filter was used to remove the 'red tail' of the LED, allowing for a better excitation of both dyes. Two photodiodes connected to transimpedance amplifiers served as photodetectors. While lacking internal amplification as compared with avalanche photodiodes and photomultipliers, photodiodes have the advantage of not requiring high voltages for operation, are robust and mechanically stable. The price per unit is lower than other photodetectors and the overall cost is also lower because specialized high voltage power supplies are not required. Finally, because the power budget of the system is low, it can be powered directly from the USB port of a computer or a laptop.
One disadvantage of photodiodes that has to be accounted for is the lack of internal amplification which significantly decreases the signal-to-noise ratio (SNR) of the detector system. The amplification has to be performed using a transimpedance amplifier to convert the photodiode's current output into voltage while simultaneously performing amplification. However, this results in the noise of the amplifier being amplified as well. Therefore, optical, electrical and algorithmic measures are implemented in order to improve SNR. First, a violet LED with emission maximum that closely matched the absorption of the sensing fluorophore (acrylodan) was chosen. This is a high-brightness LED that can deliver 20 mW optical power when driven at 20 mA dc. To increase the optical output even further, the LED was driven with a square wave signal, with the peak current at 50 mA. The resulting peak power was 47 mW. Then to ensure the highest possible excitation, the excitation optical path was designed as a folded beam (figure 3). A mirror was positioned on the wall opposing the excitation beam entrance. In this way the excitation light passes through the cuvette at least twice and some of the returning light gets reflected from the surfaces of the excitation filter as well as from the LED back reflector. To minimize the amount of scattered excitation light directed at the photodetectors, the excitation light is positioned in a right-angle configuration. This minimizes the amount of Rayleigh scattering ideally bringing it to zero. To allow only the emission light to reach the photodetectors, bandpass filters were employed that select the 'red' and the 'green' band. These two bands do not overlap. As the interference filters reflect the out-of-band light, each filter acts as a mirror for the other filter. In other words, the 'green band' filter reflects the 'red band' fluorescence, and vice versa. Because the dimensions of the cuvette cavity were practically equal to the photodiode surface, a significant percentage of the emission from the solution (>50%) is captured. In this way, the signal was amplified exclusively using optical means.
To further improve the SNR, rational design was implemented by transimpedance/secondary amplification stages. Amplifications higher than 10 8 in the first stage are not practical, requiring the use of resistors bigger than 10 M . These values are approaching the surface impedance of the printed circuit board. At impedances higher than 20 M , surface leakage currents are likely to start affecting the electronics operation unless a special design is implemented (e.g. use of Teflon standoffs). This would have significantly increased the complexity and the cost of the system. Therefore, the bulk of the amplification ( 10 7 ) was performed in the first stage, while the second stage amplification was only 20. In this way, the amplification of the noise from the input amplifier was kept to the minimum. The first and the second stages were separated galvanically by a capacitor, effectively converting the second stage into a high-pass filter tuned to allow passage of frequencies above 1 kHz. Together with the first stage, which acted as a low-pass filter (cut-off frequency 10 kHz), the amplifiers effectively suppressed the noise on frequencies that were out of band. In order to further suppress the noise, 'software lock-in' technique was implemented, as described in the experimental section.
As a result, the standard deviation of the measurement coming from the electronics noise at any light intensity was ± 1 bit of the intensity. The SNR was better than 300:1 in both the bands. These measurements were performed using high stability dye standards that were adjusted to intensities similar to that observed with the actual protein. The SNR reported here is the worst SNR observed in the reference channelthe intensities in the 'red' band are routinely around 300 ± 1 counts when monitoring rhodamine in ethanol. SNR in the measurement channel is higher, as the readout was slightly higher. As a result the intensity ratio can be measured with high precision ensuring the high resolution of the whole system (see below). The ultimate limiting factor for the resolution is the quality of the protein labeling and the stability of the labels in water environment. All the protein should be adequately labeled with both dyes; labeling only some of the molecules or over-labeling (attaching more than one label molecule per protein molecule) will affect both the calibration curve and the fluorescence intensity readout, resulting in variations of the sensor precision. Additionally, with prolonged illumination the sample starts bleaching, resulting in intensity drop in both channels. This again affects the resolution and the SNR.
The visual interface of the system is shown in figure 4 . The Labview program not only visualizes the fluorescence intensity in the 'red' and the 'green' bands, but also displays a time course of the measurements and calculates the ratio of the two intensities. It gives an option to account for the possible offsets (i.e. due to electronics heat-up) and subtracts them from the absolute measurements. Additionally, it saves the results from measurements. Each record of measurement can be tagged with a separate label for easier identification.
System testing and calibration
The first test was to run the fluorometer continuously without changing the concentration of the labeled sensing protein or glucose concentration. It was immediately obvious that the dyes bleach and the signal decreases relatively quickly ( figure 4 ). This is a very common phenomenon, but it is especially problematic in situations where the sample volume is low, and the intensity of the excitation is high (e.g., in fluorescence microscopy). Furthermore, we observed different bleaching rates for the two dyes. Differential bleaching would result in gradual worsening of the SNR and a calibration shift. Therefore, the number of measurements was limited to ten, to avoid prolonged exposure of the dyes to light without sacrificing the precision.
Next, the system was calibrated according to the procedure described in the methods section. An average of the collected ten ratios per glucose measurement was calculated and the result is plotted in figure 5 , left. For comparison, the spectra of the test solutions were obtained on the labgrade fluorometer ( figure 5, right) . As the reading of the intensity is fairly noisy due to high amplification and relatively low concentration of the sensing proteins, the peak value was calculated as average of the intensities in the range of ± 10 nm of the peak. This in effect is equivalent to opening the monochromator slits in order for the photomultiplier to sense relatively wide bands in 'green' and 'red'.
As can be seen, the calibration curves from the lab fluorometer and the portable system strongly resemble each other. In fact, they correlate extremely well with a correlation coefficient of 0.9855. The reasons for the difference in ratios for the lab fluorometer and the microfluorometer are several. First, no attempts were made to correct for the different spectral sensitivity in the portable fluorometer; the readout of the lab fluorometer is spectrally corrected through its software for the variations in the sensitivity of the photomultiplier tube. It should be noted that the sensitivity of the silicon photodiodes is approximately 20% higher in the 'red' band as compared with the sensitivity in the 'green' band. Furthermore, the two filters used have different bandwidths −50 nm for the 'green' and 60 nm for the 'red'. The wider bandwidth allows more light to reach the photodetector. Finally, the filter bands are not centered around the fluorescence emission peak, as is the case with an adjustable monochromator. All this results in output ratio closer to 1, as compared with a ratio ∼2 for the fluorometer. It should be also noted that standard deviation and the associated error of the measurements performed using the portable system is smaller, despite the bleaching effects. We believe the reason for this is the enhanced light collection from the optimized optical design. The resolution of the system in the range 0-2 μM is 72 nM at 95% confidence interval. With increase of the concentration above 2 μM, the sensitivity drops, but our approach still exhibits useful resolution (on the order of 0.3 μM) up to concentrations of ∼ 5 μM.
Glucose measurements from skin samples
As a real-world test, we determined the glucose on samples collected from the skin of a healthy volunteer. The results are shown in figure 6 . The blue line is the developed calibration curve of the system and is intended to serve as an 'eye guide'.
First, we measured the emission ratio of a sample where 1 μL of water was added to 80 mL solution of the duallabeled GBP in PBS. We then compared this with 40 μL of GBP solution added to 40 μL deionized water. As expected, the measured ratio was identical for both solutions with a difference of less than 0.04%, despite the absolute intensity dropping twice. This gives us confidence that the ratiometric approach performs well even in low-concentration measurements.
Then we measured three 'real' samples from our volunteers collected as described in the methods section. Sample +1 was from the skin of a healthy volunteer who had fasted for several hours (before lunch). The detected concentration in the wash was ∼1.3 μM. Sample +2 was a sample from the same person approximately 1 h after lunch. As expected, increased glucose concentration was found in the wash-approximately 1.7 μM. Finally, the wash from the skin of a healthy volunteer who consumed two chocolate bars after lunch was also measured. Even higher glucose concentration-approximately 1.8 μM-was found in that wash.
Conclusion
Presented results suggest that the microfluorometer system is a promising tool for accurate measurements of low glucose concentrations (<10 μM) in biological samples. The limit of detection was ∼0.08 μM. It compares favorably with a number of other recently published systems that target measurements of low glucose concentrations. The deviation of the measured ratios is within the measurement uncertainty. In future, we will focus on methods for decreasing the photobleaching so that a better estimate of the actual glucose concentration becomes possible. Further testing on a larger cohort of patients is also underway with comparisons between blood glucose levels.
